Hearing Aids Market Worth $10.2 Billion by 2026 - Exclusive Report by MarketsandMarkets™
In July 2020, Cochlear Ltd. (Australia) received US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and Custom Sound Pro fitting software.
View full press release